Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia

Archives of Family Medicine

Volumn 9, Issue 7, 2000, Pages 624-630

  Kaplan Machlis, B ^a   Spiegler, G E ^a   Zodet, M W ^a   Revicki, D A ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG COST; DRUG EFFICACY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0033822910     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.9.7.624     Document Type: Article

References (32)

1. Symptomatic gastroesophageal reflux: Incidence and precipitating factors
2. The prevalence and impact of gastroesophageal reflux disease in the United States: A population-based study
3. The impact of gastroesophageal reflux disease on health-related quality of life
4. Health-related quality of life in primary care patients with gastroesophageal reflux disease
5. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment
6. Gastroesophageal reflux disease
7. Ranitidine therapy for gastroesophageal reflux disease
8. Ranitidine in the treatment of symptomatic gastroesophageal reflux disease
9. Double-blind cross-over study of ranitidine and placebo in gastro-oesophageal reflux disease
10. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: A clinical experience network (CEN) study
11. Omeprazole or ranitidine in the treatment of reflux esophagitis: Results of a double-blind, randomized, Scandinavian multicenter study
12. Drug therapy: Omeprazole
13. Omeprazole vs ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease
14. Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux disease
15. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine: Results from a multicentre clinical trial
16. Omeprazole is more effective than cimetidine for the relief of all grades of gastro-oesophageal reflux disease-associated heartburn, irrespective of the presence or absence of endoscopic oesophagitis
17. A comparison of five maintenance therapies for reflux esophagitis
18. The GERD outcomes trial: Effectiveness and costs of omeprazole vs ranitidine in empiric treatment of heartburn in primary care practice
19. Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease
20. Pharmacoeconomic evaluation in the real world: Effectiveness vs efficacy studies
21. Gastroesophageal reflux
22. GSRS: A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease
23. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease
24. The Psychological General Well-Being (PGWB) Index
25. Evaluating the psychometric characteristics of the Psychological General Well-Being Index with a new response scale
26. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastroesophageal reflux disease
27. Quality of life (QoL) in the long-term management of gastroesophageal reflux disease treated with omeprazole (OME) or antireflux surgery (ARS): Results of a multicentre randomized clinical trial
28. Gastro-oesophageal reflux disease in primary care: An international study of different treatment strategies with omeprazole
29. Quality of life in patients with heart-burn but without esophagitis: Effects of treatment with omeprazole